Form 8-K - Current report:
SEC Accession No. 0001213900-24-101222
Filing Date
2024-11-22
Accepted
2024-11-22 08:00:07
Documents
15
Period of Report
2024-11-19
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0222160-8k_nukkleus.htm   iXBRL 8-K 29611
2 SECURITIES PURCHASE AGREEMENT DATED NOVEMBER 19, 2024 ea022216001ex10-1_nukkleus.htm EX-10.1 124179
  Complete submission text file 0001213900-24-101222.txt   401135

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nukk-20241119.xsd EX-101.SCH 3820
4 XBRL DEFINITION FILE nukk-20241119_def.xml EX-101.DEF 26706
5 XBRL LABEL FILE nukk-20241119_lab.xml EX-101.LAB 36887
6 XBRL PRESENTATION FILE nukk-20241119_pre.xml EX-101.PRE 25330
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0222160-8k_nukkleus_htm.xml XML 5869
Mailing Address 525 WASHINGTON BLVD JERSEY CITY NJ 07310
Business Address 525 WASHINGTON BLVD JERSEY CITY NJ 07310 212-791-4663
Nukkleus Inc. (Filer) CIK: 0001787518 (see all company filings)

EIN.: 383912845 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-39341 | Film No.: 241486463
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)